Circulating Natriuretic Peptide Concentrations in Patients With End-Stage Renal Disease: Role of Brain Natriuretic Peptide as a Biomarker for Ventricular Remodeling

This publication has 19 references indexed in Scilit:

• Renal actions of synthetic Dendroaspis natriuretic peptide
  Kidney International, 1999
• Brain Natriuretic Peptide Is a Sensitive Indicator of Impaired Left-Ventricular Function in Elderly Patients with Cardiovascular Disease
  Cardiology, 1997
• Superiority of Brain Natriuretic Peptide as a Hormonal Marker of Ventricular Systolic and Diastolic Dysfunction and Ventricular Hypertrophy
  Hypertension, 1996
• Outcome and risk factors for left ventricular disorders in chronic uraemia
  Nephrology Dialysis Transplantation, 1996
• Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
  American Journal of Kidney Diseases, 1996
• Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
  Kidney International, 1995
• Impact of left ventricular hypertrophy on survival in end-stage renal disease
  Kidney International, 1989
• Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human
  Science, 1986
• Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
  Published by Elsevier ,1986
• Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
  Circulation, 1978